Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway

Cancer Letters

Volumn 355, Issue 2, 2014, Pages 264-272

  Shao, Yan ^a   Lo, Chung Mau ^a   Ling, Chang Chun ^a   Liu, Xiao Bing ^a   Ng, Kevin Tak Pan ^a   Chu, Andrew Chi Yuen ^a   Ma, Yuen Yuen ^a   Li, Chang Xian ^a   Fan, Sheung Tat ^a   Man, Kwan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bregs; HCC; Invasion

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADVANCED CANCER; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CANCER INFILTRATION; CANCER STAGING; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LYMPHOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; REGULATORY B CELL; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; TUMOR RECURRENCE; VENOUS INFILTRATION; ANIMAL; CELL GROWTH; CELL MOTION; DISEASE COURSE; IMMUNOLOGY; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES, REGULATORY; CARCINOMA, HEPATOCELLULAR; CD40 LIGAND; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, SCID; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION;

EID: 84908179054     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.09.026     Document Type: Article

References (26)

1. Spangenberg H.C., Thimme R., Blum H.E. Targeted therapy for hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol 2009, 6:423-432.
2. Schneider C., Teufel A., Yevsa T., Staib F., Hohmeyer A., Walenda G., et al. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer. Gut 2012, 61:1733-1743.
3. Kessel A., Haj T., Peri R., Snir A., Melamed D., Sabo E., et al. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun. Rev 2011, 11:670-677.
4. Horikawa M., Minard-Colin V., Matsushita T., Tedder T.F. Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. J. Clin. Invest 2011, 121:4268-4280.
5. Blair P.A., Norena L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010, 32:129-140.
6. Bouaziz J.D., Calbo S., Maho-Vaillant M., Saussine A., Bagot M., Bensussan A., et al. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur. J. Immunol 2010, 40:2686-2691.
7. Mauri C., Bosma A. Immune regulatory function of B cells. Annu. Rev. Immunol 2012, 30:221-241.
8. Amu S., Saunders S.P., Kronenberg M., Mangan N.E., Atzberger A., Fallon P.G. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J. Allergy Clin. Immunol 2010, 125:1114-1124. e1118.
9. Olkhanud P.B., Damdinsuren B., Bodogai M., Gress R.E., Sen R., Wejksza K., et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4(+) T cells to T-regulatory cells. Cancer Res 2011, 71:3505-3515.
10. Ammirante M., Luo J.L., Grivennikov S., Nedospasov S., Karin M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 2010, 464:302-305.
11. Yang M., Sun L., Wang S., Ko K.H., Xu H., Zheng B.J., et al. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J. Immunol 2010, 184:3321-3325.
12. Yanaba K., Bouaziz J.D., Matsushita T., Tsubata T., Tedder T.F. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol 2009, 182:7459-7472.
13. Bodogai M., Lee Chang C., Wejksza K., Lai J., Merino M., Wersto R.P., et al. Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L. Cancer Res 2013, 73:2127-2138.
14. Lin J.C., Shih Y.L., Chien P.J., Liu C.L., Lee J.J., Liu T.P., et al. Increased percentage of B cells in patients with more advanced hepatocellular carcinoma. Hum. Immunol 2010, 71:58-62.
15. Wang K., Yang R.L., Pei H., Wu H.Y., Zhang J., Huang B. The expression profile of Fc Receptor-like Y in B lymphocytes with hepatitis B virus induced diseases. Folia Histochem. Cytobiol 2011, 49:405-409.
16. Doi H., Iyer T.K., Carpenter E., Li H., Chang K.M., Vonderheide R.H., et al. Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-Positive B-cell population. Hepatology 2011, 55:709-719.
17. Lin M., Ma S.P., Lin H.Z., Ji P., Xie D., Yu J.X. Intratumoral as well as peritumoral lymphatic vessel invasion correlates with lymph node metastasis and unfavourable outcome in colorectal cancer. Clin. Exp. Metastasis 2010, 27:123-132.
18. Lee T.K., Man K., Ho J.W., Wang X.H., Poon R.T., Xu Y., et al. FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin. Cancer Res 2005, 11:8458-8466.
19. Man K., Ng K.T., Xu A., Cheng Q., Lo C.M., Xiao J.W., et al. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling. Clin. Cancer Res 2010, 16:967-977.
20. Fujiwara Y., Shiba H., Furukawa K., Iida T., Sakamoto T., Gocho T., et al. Perioperative change in white blood cell count predicts outcome of hepatic resection for hepatocellular carcinoma. J. Hepatobiliary Pancreat. Sci 2010, 17:892-897.
21. Jenkins S.J., Perona-Wright G., MacDonald A.S. Full development of Th2 immunity requires both innate and adaptive sources of CD154. J. Immunol 2008, 180:8083-8092.
22. Kasper H.U., Drebber U., Stippel D.L., Dienes H.P., Gillessen A. Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma. World J. Gastroenterol 2009, 15:5053-5057.
23. Kondo Y., Ninomiya M., Kakazu E., Kimura O., Shimosegawa T. Hepatitis B surface antigen could contribute to the immunopathogenesis of hepatitis B virus infection. ISRN Gastroenterol 2013, 2013. 935295.
24. Budhu A., Wang X.W. The role of cytokines in hepatocellular carcinoma. J. Leukoc. Biol 2006, 80:1197-1213.
25. Calzascia T., Pellegrini M., Hall H., Sabbagh L., Ono N., Elford A.R., et al. TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice. J. Clin. Invest 2007, 117:3833-3845.
26. Smith H.A., Kang Y. The metastasis-promoting roles of tumor-associated immune cells. J. Mol. Med. (Berl) 2013, 91:411-429.